The UCI has announced that Nairo Quintana had been disqualified from the 2022 Tour de France after testing positive for tramadol on two occasions during the race.
The Colombian finished sixth in the race but returned samples containing “the presence of tramadol and its two main metabolites” on stage 7 and stage 11 of the race at La Planche des Belles Filles and the Col de Granon.
Since March 2019, Tradamol has been banned for in-competition use, though testing positive for tramadol doesn’t constitute an anti-doping rule violation. As such, Quintana is free to continue competing and won’t be subject to a racing ban.
More to come…
Daniel Ostanek is production editor at Cyclingnews, having joined in 2017 as a freelance contributor and later being hired as staff writer. Prior to joining the team, he had written for most major publications in the cycling world, including CyclingWeekly, Rouleur, and CyclingTips.
Daniel has reported from the world’s top races, including the Tour de France and the spring Classics, and has interviewed many of the sport’s biggest stars, including Wout van Aert, Remco Evenepoel, Mark Cavendish, Demi Vollering, and Anna van der Breggen.
As well as original reporting, news and feature writing, and production work, Daniel also runs The Leadout newsletter and oversees How to Watch guides throughout the season. His favourite races are Strade Bianche and the Volta a Portugal, and he rides a Colnago C40.
Click Here to Read the Full Original Article at CyclingNews RSS Feed…